Mycroft-West, C.J.; Devlin, A.J.; Cooper, L.C.; Guimond, S.E.; Procter, P.; Guerrini, M.; Miller, G.J.; Fernig, D.G.; Yates, E.A.; Lima, M.A.;
et al. Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer’s Disease β Secretase, BACE1. Mar. Drugs 2021, 19, 203.
https://doi.org/10.3390/md19040203
AMA Style
Mycroft-West CJ, Devlin AJ, Cooper LC, Guimond SE, Procter P, Guerrini M, Miller GJ, Fernig DG, Yates EA, Lima MA,
et al. Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer’s Disease β Secretase, BACE1. Marine Drugs. 2021; 19(4):203.
https://doi.org/10.3390/md19040203
Chicago/Turabian Style
Mycroft-West, Courtney J., Anthony J. Devlin, Lynsay C. Cooper, Scott E. Guimond, Patricia Procter, Marco Guerrini, Gavin J. Miller, David G. Fernig, Edwin A. Yates, Marcelo A. Lima,
and et al. 2021. "Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer’s Disease β Secretase, BACE1" Marine Drugs 19, no. 4: 203.
https://doi.org/10.3390/md19040203
APA Style
Mycroft-West, C. J., Devlin, A. J., Cooper, L. C., Guimond, S. E., Procter, P., Guerrini, M., Miller, G. J., Fernig, D. G., Yates, E. A., Lima, M. A., & Skidmore, M. A.
(2021). Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer’s Disease β Secretase, BACE1. Marine Drugs, 19(4), 203.
https://doi.org/10.3390/md19040203